Replies to post #161791 on Biotech Values

[oc631]

By the time ACHN figures it all out there won't be any HCV patients left in developed markets.

Since there continues to be buyers at this level I would be interested in hearing a fundamental reason to own this stock.

Are investors still waiting for a large pharma buyout? Is the smart money really this dumb? Let's hear the case.